BAAM
FLGT icon

Baker Avenue Asset Management’s Fulgent Genetics FLGT Stock Holding History

Baker Avenue Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11
Closed -$294 – 761
2023
Q3 		$294 Sell
11
-7
-39% -$239 ﹤0.01% 1566
2023
Q2 		$667 Sell
18
-44
-71% -$1.53K ﹤0.01% 1311
2023
Q1 		$1.94K Buy
+62
New +$2K ﹤0.01% 997

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baker Avenue Asset Management's FLGT Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 11 shares — an estimated $294 sold.

Baker Avenue Asset Management first reported a position in FLGT in Q1 2023 and held it in 3 quarters. The position peaked at $1.94K in Q1 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 11 Fulgent Genetics shares in Q4 2023, an estimated $294.
  • Baker Avenue Asset Management first reported a position in Fulgent Genetics in Q1 2023 and held it in 3 quarters.
  • Baker Avenue Asset Management's Fulgent Genetics position peaked at $1.94K in Q1 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.